TargetMol

Tafluposide

Product Code:
 
TAR-T28912
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T28912-5mg5mg£711.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Tafluposide is a DNA topoisomerase inhibitor with anti-tumor activity.
CAS:
179067-42-6
Formula:
C45H35F10O20P
Molecular Weight:
1116.713
Purity:
0.98
SMILES:
[H][C@]12COC(=O)[C@]1([H])[C@H](c1cc(OC)c(OP(O)(O)=O)c(OC)c1)c1cc3OCOc3cc1[C@H]2O[C@@H]1O[C@@H]2COC(C)O[C@H]2[C@H](OC(=O)COc2c(F)c(F)c(F)c(F)c2F)[C@H]1OC(=O)COc1c(F)c(F)c(F)c(F)c1F

References

1. Kluza J, Mazinghien R, Irwin H, Hartley JA, Bailly C. Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. Anticancer Drugs. 2006 Feb;17(2):155-64. PubMed PMID: 16428933. 2. Pujol MD, Romero M, S?nchez I. Synthesis and biological activity of new class of dioxygenated anticancer agents. Curr Med Chem Anticancer Agents. 2005 May;5(3):215-37. Review. PubMed PMID: 15992351. 3. Kruczynski A, Barret JM, Van Hille B, Chansard N, Astruc J, Menon Y, Duchier C, Cr?ancier L, Hill BT. Decreased nucleotide excision repair activity and alterations of topoisomerase IIalpha are associated with the in vivo resistance of a P388 leukemia subline to F11782, a novel catalytic inhibitor of topoisomerases I and II. Clin Cancer Res. 2004 May 1;10(9):3156-68. PubMed PMID: 15131057. 4. Jensen LH, Renodon-Corni?re A, Nitiss KC, Hill BT, Nitiss JL, Jensen PB, Sehested M. A dual mechanism of action of the anticancer agent F 11782 on human topoisomerase II alpha. Biochem Pharmacol. 2003 Aug 15;66(4):623-31. PubMed PMID: 12906927.